Incidental Gallbladder Carcinoma :Incidence and Clinical Significance in Specimens From Routine Cholecystectomies in Sohag Locality
1 other identifier
observational
100
1 country
1
Brief Summary
Incidental gallbladder carcinoma :Incidence and clinical significance in specimens from routine cholecystectomies in sohag locality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2026
CompletedFirst Submitted
Initial submission to the registry
October 14, 2026
CompletedFirst Posted
Study publicly available on registry
October 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 21, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 22, 2027
October 21, 2026
September 1, 2026
8 months
October 14, 2026
October 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of gallbladder carcinoma
incidence of gallbladder carcinoma in histopathology
6 months
Study Arms (1)
all patient performed cholecystectomy
Interventions
histopathology of gall bladder after cholycystectomy
Eligibility Criteria
The study will involve patients undergoing elective or emergency cholecystectomy at Sohag University Hospital for presumed benign gallbladder disease, including symptomatic cholelithiasis, acute calculous cholecystitis, chronic calculous cholecystitis, gallbladder mucocele, empyema, or gallbladder polyps without confirmed preoperative malignancy
You may qualify if:
- Patients undergoing cholecystectomy either lap or open or lap converted into open.
- Patients whose gallbladder specimens are available for complete histopathological examination.
- Patients who provide written informed consent to participate in the study.
- Patients of both sexes and all eligible adult age groups.
You may not qualify if:
- Patients with preoperatively confirmed gallbladder carcinoma.
- Patients undergoing cholecystectomy as part of planned oncological surgery for another malignancy.
- Patients with missing, damaged, or inadequately preserved gallbladder specimens.
- Patients with incomplete clinical or histopathological data.
- Patients refusing participation or postoperative follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- yahia.abdelrasol@med.sohag.edu.eg
Study Record Dates
First Submitted
October 14, 2026
First Posted
October 21, 2026
Study Start
September 20, 2026
Primary Completion (Estimated)
May 21, 2027
Study Completion (Estimated)
May 22, 2027
Last Updated
October 21, 2026
Record last verified: 2026-09